Sarah Condella is VP at EXACT SCIENCES CORP (EXAS). They have made 18 open-market trades across 1 company since 2021, most recently 2026-03-23.
CIK 0001839989
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 18 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EXAS | 191,891 | $20.1M |
Shares reported on the most recent Form 4, priced at the 2026-03-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EXAS | SELL · 10b5-1 | 2024-05-01 | 2024-05-02 | $60.15 | $6K | -13.6% | -28.3% | -26.9% |
| EXAS | SELL · 10b5-1 | 2024-04-01 | 2024-04-03 | $70.00 | $140K | -11.0% | -15.4% | -41.2% |
| EXAS | SELL · 10b5-1 | 2024-03-28 | 2024-04-01 | $70.00 | $140K | -8.3% | -24.6% | -46.7% |
| EXAS | SELL · 10b5-1 | 2024-03-01 | 2024-03-04 | $59.32 | $205K | +0.1% | +24.5% | -23.4% |
| EXAS | SELL · 10b5-1 | 2024-02-27 | 2024-02-28 | $56.89 | $214K | +6.4% | +23.4% | -17.6% |
| EXAS | SELL · 10b5-1 | 2024-02-23 | 2024-02-26 | $59.72 | $122K | +6.0% | +15.4% | -18.9% |
| EXAS | SELL · 10b5-1 | 2024-02-22 | 2024-02-23 | $59.78 | $121K | -1.3% | +11.8% | -5.2% |
| EXAS | SELL · 10b5-1 | 2024-02-21 | 2024-02-22 | $61.50 | $133K | -2.1% | +6.7% | -10.5% |
| EXAS | SELL · 10b5-1 | 2024-02-15 | 2024-02-16 | $61.43 | $119K | -4.1% | -1.9% | -13.4% |
| EXAS | SELL · 10b5-1 | 2024-01-02 | 2024-01-04 | $73.50 | $147K | -8.8% | -11.1% | +3.7% |
| EXAS | SELL · 10b5-1 | 2023-12-14 | 2023-12-18 | $70.00 | $140K | +13.0% | -2.2% | -10.1% |
| EXAS | SELL · 10b5-1 | 2023-09-01 | 2023-09-06 | $84.36 | $380K | -6.7% | -22.4% | -19.8% |
| EXAS | SELL · 10b5-1 | 2023-05-10 | 2023-05-12 | $80.00 | $487K | +3.8% | +14.7% | +3.9% |
| EXAS | SELL · 10b5-1 | 2023-05-01 | 2023-05-03 | $63.78 | $64K | +27.9% | +32.5% | +52.5% |
| EXAS | SELL · 10b5-1 | 2023-04-03 | 2023-04-05 | $67.19 | $67K | +2.3% | +5.3% | +47.2% |
| EXAS | SELL | 2023-03-01 | 2023-03-02 | $62.00 | $62K | -0.5% | +3.0% | +25.9% |
| EXAS | SELL | 2023-02-28 | 2023-03-01 | $61.12 | $357K | +3.6% | +10.6% | +32.3% |
| EXAS | SELL | 2023-02-22 | 2023-02-23 | $62.72 | $130K | +10.0% | +11.2% | +37.3% |
| EXAS | SELL | 2023-02-16 | 2023-02-17 | $63.91 | $138K | +1.0% | +1.8% | +30.5% |
| EXAS | SELL | 2023-02-15 | 2023-02-16 | $65.59 | $125K | -0.1% | +1.5% | +25.8% |
| EXAS | SELL | 2023-02-01 | 2023-02-03 | $67.93 | $68K | -0.6% | +0.8% | -1.2% |
| EXAS | SELL | 2023-01-09 | 2023-01-11 | $60.00 | $60K | -3.0% | -4.9% | -0.8% |
| EXAS | SELL | 2022-03-01 | 2022-03-02 | $76.69 | $432K | -22.5% | -0.2% | -34.2% |
| EXAS | SELL | 2022-02-25 | 2022-03-01 | $74.29 | $458K | -17.2% | -7.7% | -34.3% |
| EXAS | SELL | 2022-02-24 | 2022-02-25 | $70.10 | $661K | -8.2% | -13.8% | -36.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.